期刊文献+

子宫内膜癌组织中雌激素及孕激素受体亚型的表达研究 被引量:4

Expression of estrogen and progesterone receptor subtypes in human endometrial carcinoma tissues
原文传递
导出
摘要 目的探讨子宫内膜癌组织中雌激素受体(ER)亚型mRNA及孕激素受体(PR)亚型mRNA和蛋白表达水平的变化及其意义。方法采用RT-PCR法检测66例子宫内膜癌和30例正常子宫内膜组织ER、PR亚型mRNA的表达,采用蛋白印迹法检测PR亚型蛋白的表达。结果(1)ERαmRNA在子宫内膜癌和正常子宫内膜组织中的表达水平分别是8.00±7.77、3.84±2.57,而ERβmRNA的表达水平分别是4.15±3.55、0.41±0.29,子宫内膜癌组织中ERα、ERβmRNA表达水平均高于正常子宫内膜,两种组织间分别比较,差异均有统计学意义(P<0.05)。(2)PR、PRA和PRB蛋白表达及PR mRNA表达的降低与子宫内膜癌的发生有关(P<0.05),而PRA与PRB蛋白表达的比值和PRB mRNA的表达与子宫内膜癌的发生无明显相关性(P值分别为0.550、0.901)。(3)子宫内膜癌组织中PRB mRNA与ERβmRNA的表达水平呈正相关关系(r=0.43,P<0.01)。结论子宫内膜癌组织中ER亚型mRNA表达上调、PR蛋白和mRNA表达的下调可能参与了子宫内膜癌的发生;PRB mRNA与ERβmRNA表达呈正相关关系。 Objective To investigate the expressions of estrogen receptor (ER) and progesterone receptor (PR) subtypes in human endometrial carcinoma tissues. Methods Thirty samples of normal endometrial tissue and 66 endometrial carcinomas were investigated using western blot assays and reversetranscription polymerase chain reaction. Results (1)Both ERα and ERβ mRNA were significantly increased in endometrial carcinoma compared with that in normal endometrium tissues. The relative value of ERα and ERβ mRNA in endometrial carcinoma was 8.00 ± 7.77, 3.84 ± 2. 57 and that in normal endometrium tissues was 4. 15 ±3.55, 0. 41 ±0. 29, respectively. (2) Decreased levels of PR, PRA, PRB protein and PR mRNA were associated with endometrium carcinogenesis ( P 〈 0. 05 ), while PRB mRNA expression and the ratio of PRA/PRB was not. (3) Expression of PRB mRNA was associated with ERβ mRNA (r = 0. 43, P 〈 0. 01 ). Conclusion Overexpression of ER subtypes and down-regulation of PR may be involved in the pathogenesis of endometrial carcinoma, and expression of PRB mRNA is associated with ERβ but not ERα mRNA.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2005年第11期752-755,共4页 Chinese Journal of Obstetrics and Gynecology
基金 国家自然科学基金资助项目(30170977)
关键词 受体 雌激素 受体 孕酮 子宫内膜肿瘤 Receptors, estrogen Receptors, progesterone Endometrial neoplasms
  • 相关文献

参考文献6

  • 1Utsunomiya H, Suzuki T, Harada N, et al. Analysis of estrogen receptor alpha and beta in endometfial carcinomas: correlation with ER beta and clinicopathologic findings in 45 cases. Int J Gynecol Pathol. 2000. 19: 335-341.
  • 2吴成 廖秦平.雌激素受体亚型mRNA在子宫内膜癌组织中的表达[J].中国妇产科临床杂志,2003,4:198-200.
  • 3温宏武.雌激素受体βmRNA在子宫内膜癌中的表达及其意义[J].中华妇产科杂志,2001,36(2):108-110. 被引量:3
  • 4Smid-Koopman E, Blok LJ, Kuhne LC, et al. Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endometrial carcinoma cell lines. J Soc Gynecol Investig , 2003, 10:49-57.
  • 5Gao J, Mazella J, Tang M, et al. Ligand-activated progesterone receptor isoform hPR-A is a stronger transactivator than hPR-B for the expression of IGFBP-1 ( insulin-like growth factor binding protein-1 )in human endometrial stromal cells. Mol Endocrinol, 2000, 14:1954-1961.
  • 6廖秦平,郑虹.孕激素受体A和B亚型在子宫内膜癌中的临床意义[J].北京大学学报(医学版),2004,36(6):616-619. 被引量:4

二级参考文献11

  • 1Lau K M,Proc Nat Acad Sci USA,1999年,96卷,5722页
  • 2曹泽毅,妇科肿瘤学,1998年,209页
  • 3Martin L, Das RM, Finn CA, et al. The inhibition by progesterone of uterine epithelial proliferation in the mouse [ J ]. J Endocrinol,1973, 57: 549 -554
  • 4Elwood M, Cole P, Rothman KJ,et al. Epidemiology of endometrial cancer[ J]. J Natl Cancer Inst, 1977, 59:1055 - 1060
  • 5Ehrlich CE, Young PC, Cleary RE. Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: Therapeutic implications[J]. Am J Obstet Gynecol, 1981,141: 539 - 546
  • 6Fukuda K, Mori M, Uchiyama M, et al. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma[J]. Gynecol Oncol, 1998 , 69:220 -225
  • 7Snijders MP, de Goeij AF, Koudstaal J, et al. Oestrogen and progesterone receptor immunocytochemistry in human hyperplastic and neoplastic endometrium[J]. J Pathol, 1992, 166: 171-177
  • 8Arnett-Mansfield RL, deFazio A, Wain GV, et al. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium[J]. Cancer Res, 2001,61: 4576 -4582
  • 9Nyholm HC, Nielsen AL, Lyndrup J, et al. Biochemical and immunohistochemical estrogen and progesterone receptors in adenomatous hyperplasia and endometrial carcinoma: correlations with stage and other clinicopathologic features [ J ]. Am J Obstet Gynecol,
  • 10Carcangiu ML, Chambers JT, Voynick IM, et al. Immunohistochemical evaluation of estrogen and progesterone receptor content in 183patients with endometrial carcinoma. Part Ⅰ: Clinical and histologic correlations [ J ]. Am J Clin Pathol, 1990, 94:247 - 254

共引文献9

同被引文献37

  • 1拉莱.苏祖克,彭玉华,周康,房新志,王莉.新疆不同民族子宫颈癌发病趋势分析[J].新疆医科大学学报,2006,29(7):569-571. 被引量:81
  • 2肖觉,宋容,叶学正,李进.ER PR和p16联合检测在子宫内膜腺癌和宫颈腺癌鉴别诊断中的应用[J].四川肿瘤防治,2007,20(2):121-123. 被引量:2
  • 3王巧莲,梁元姣,吴元赭,郝群,卓士超.来曲唑对人子宫内膜癌细胞作用的研究[J].医学研究生学报,2007,20(6):627-630. 被引量:14
  • 4Saegusa M, Okayasu I. Changes in expression of estrogen receptors alpha and beta in relation to progesterone receptor and pS2 status in normal and malignant endometrium [ J ]. Jpn J Cancer Res,2000,91 (5) :510-518.
  • 5Gaillard S, Dwyer MA, McDonnell DP. Definition of the molecular basis for estrogen receptor-related receptor-α-cofactor interactions[ J]. Molecular Endocrinology, 2007,21 ( 1 ) :62-76.
  • 6Sun PM, Gao M, Wei LH, et al. An estrogen receptor a-dependent regulation of estrogen receptor-related receptor a in the proliferation of endometrial carcinoma cells [ J ]. Int J Gynecol Cancer, 2006,16 ( Suppl2 ) :564-568.
  • 7Ariazi EA, Clark GM, Mertz JE. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer [J]. Cancer Res,2002,62(22) :6510-6518.
  • 8Ariazi EA, Jordan VC. Estrogen-related receptors as emerging targets in cancer and metabolic disorders [J]. Current Topics Medicinal Chemistry, 2006, 6 ( 3 ) :203-215.
  • 9Kraus RJ, Ariazi EA, Farrell ML, et al. Estrogen-related receptor alpha 1 actively antagonizes estrogen receptor-regulated transcription in MCF-7 mammary cells[J]. J Biol Chem,2002,277 ( 27 ) :24826-24834.
  • 10Kellert IM, Botterweck AA, Huveneers JA, et al. Trends in incidence of and mortality from uterine and ovarian cancer in Mid and South Limburg, The Netherlands, 1986-2003 [J]. Eur J Cancer Prev,2009,18( 1 ) :85-89.

引证文献4

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部